The First Crosslinked Dermal Filler with HA + PN
Prodermis is revolutionising medical aesthetics by combining Hyaluronic Acid (HA) with Polynucleotides (PN) — enhancing hydration, regeneration, and long-lasting volume like never before.
Redefining Aesthetics
Prodermis is revolutionising aesthetic medicine with the world’s first dermal fillers to unite Hyaluronic Acid and Polynucleotides. Alongside advanced boosters and clinical skincare, our portfolio delivers natural, lasting transformation — empowering practitioners to correct, revitalise, and enhance at every stage of treatment.
.webp)
.png)
.png)
Upcoming events
.png)
PRODERMIS at Dubai Derma 2026: Expanding the Frontiers of Regenerative Aesthetics
We’re delighted to announce our participation in Dubai Derma 2026, the largest scientific skincare and dermatology event in the Middle East, Africa, and the Indian Subcontinent. Held at the Dubai World Trade Centre, the congress unites global experts, researchers, and industry leaders to exchange knowledge and showcase the latest innovations shaping the future of dermatology and aesthetics.
PRODERMIS at AMWC Monaco 2026: Next Generation of Aesthetic Innovation
We’re proud to announce our participation in AMWC Monaco 2026, the world’s leading congress in aesthetic and anti-ageing medicine. Hosted at the prestigious Grimaldi Forum in Monte Carlo, this internationally renowned event brings together top physicians, scientists, and industry experts to explore the latest advancements in medical aesthetics and regenerative science.
PRODERMIS at IMCAS Paris 2026: Introducing PROSCULPT™ and the New PRODERMIS Skincare Line
We’re delighted to announce our participation in IMCAS Paris 2026, one of the world’s most prestigious events in dermatology, plastic surgery, and aesthetic science. Taking place at the Palais des Congrès de Paris, this annual congress gathers global leaders, innovators, and practitioners to explore the future of medical aesthetics.
